/Investor DB

Inkef — 2021 Investments

3 investments dated 2021 · listed companies and verified rows first · show all

Cardior Pharmaceuticals GmbHcardior.deSeries B · Aug 2021 · $75M

Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.

Co-investorsBioMedPartnersHadean VenturesEQT Life SciencesFund+Sunstone Capital

Lengoolengoo.cominFeb 2021Defunct

Lengoo was a Berlin-based B2B startup offering AI-powered machine translation software that trained custom models on each enterprise client's own language data, combined with professional human linguists.

Berlin, DE

Co-investorsCreathor VenturesHOWZAT PartnersPolipo VenturesRheingau FoundersTechstarsPiton Capital LLP+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Anavo Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.